atezolizumab,bevacizumab
roche
['commit', 'biotec']
we are committed to addressing areas of high unmet medical need, and our diverse pipeline includes innovative medicines in a broad range of therapeutic areas, starting with oncology. learn more from our chief medical officer, joseph e. eid, md. #asco2022
A new kind of biotech company with the mission to make innovative medicines available, accessible, and affordable to anyone, anywhere.